Get Matched With The Right Drug And Alcohol Treatment At Treatment-Centers.net

For a drug or alcohol treatment to work, it must be the right treatment for the client. Many addicts struggle to find a drug and alcohol treatment center that fits them, though, which makes the service Treatment-Centers.net provides not only valuable but also vital to an addict’s long-term sobriety. The website and comprehensive directory include informational listings for more than 11,000 drug and alcohol treatment centers and professionals, plus confidential assessments and 24-hour live phone assistance to help the addict navigate the many treatment options in his area. Treatment-Centers.net does not charge the person seeking drug and/or alcohol treatment during any step of the referral process, and it also offers a robust community area on the website in which addicts can participate in forums and chats with others in similar situations.


When it comes to matching addicts with a drug and alcohol treatment center, Treatment-Centers.net leads by example. Recovering addict Bernie Grohsman created the directory to help others like him find the drug and alcohol treatment they need to battle addiction and regain control of their lives. The directory contains more than 11,000 listings for drug and alcohol treatment centers and professionals, and the website offers live phone assistance from addiction specialists trained to assist the addict during the assessment process and match him with the right drug and alcohol rehabilitation center. Treatment-Centers.net surpasses all other referral services in terms of comprehensiveness of listings and access to qualified professionals.

The addict begins the referral process by filling out the confidential assessment form at Treatment-Centers.net. It asks for basic, personal information and a drug and medical history. An addict also can call Treatment-Centers.net for help filling out the assessment. If the addict does fill out the assessment online, he will provide a contact phone number and an addiction specialist will call him at a designated time to discuss drug and alcohol treatment options. A loved one also can fill out the assessment and have the initial conversation with an addiction specialist. The addiction specialist will then help the addict or his loved one determine which drug and alcohol rehabilitation center will work best for him.

For those addicts not quite ready to take the important first step of asking for help, Treatment-Centers.net has a thriving community area in which they can talk with other addicts about their struggles and successes with drug and alcohol treatment. Addicts discuss their own experiences with specific drug and alcohol rehabilitation centers in the forums and chats, and this interaction often gives the addict the final push he needs to request a drug and alcohol treatment center referral for him. The community area also features a blog that includes addiction news, inspirational quotes and stories, and videos on a variety of addiction-related topics.

Via EPR Network
More Healthcare press releases

Astral Pharmaceutical Industries Will Enter United States Market Very Soon

Astral Pharmaceutical Industries, a state of the art, manufacturing facility for Sterile Antibiotic powder injectables, at Vadodara, India is a specialized and dedicated site, having independent manufacturing infrastructure for Cephalosporin and Penicillin Range of powder Injectable Drug Products.

The company headed by President & CEO Dr. Dushyant R. Patel has highly successful track record of more than a decade ,catering to the domestic, LATAM, SEA and CIS markets for the powder injectable drug products. Astral is a leading player in this segment and has been associated with MNC’s and large Indian Pharma companies. Both the manufacturing lines, one for Cephalosporin Injectable Drug Products and other for Penicillin range of injectable Drug Products have been recently granted approval by US FDA. Prior to the facility approval from USFDA Astral has received several Regulatory accreditation such as HPFBI-Canada, TGA-Australia, MCC-South Africa, ANVISA-Brazil over and above accreditation from several Semi regulated countries.

Astral will soon be entering the US market in strategic alliance with Chicago based Sagent Pharmaceutical Inc. with whom more than 15 ANDAs have been filed.

While the development projects for more ANDA’s are in pipeline, Astral is actively working on consolidating its strong regulatory profile for entry into EU markets apart from fast tracking its filings for Canada, Australia and New Zealand markets.

Continuous technology up gradation and focused development in the core competency area of sterile manufacturing operations has been the strategy of growth. Astral is poised to expand its operations in the field of specialized and niche sterile dosage forms for critical care segments and hospital products.

For further information visit http://www.astralpharma.com or contact Dr. Dushyant Patel at dushyantpatel@astralpharma.com.

Via EPR Network
More Healthcare press releases

Global Health Progress Releases New Report that Features Innovative Solutions to Improve Access to Healthcare in India

Global Health Progress’ recently released report, Innovative Solutions to Improving Health in India, summarizes how the organization is committed to building sustainable, innovative solutions to secure access to healthcare for all Indian communities.

The report notes that access to healthcare remains problematic in parts of India, especially in rural areas. For instance, forty percent of the country’s primary healthcare centers are understaffed and fewer than one in five have a telephone connection. Nearly one million Indians die every year due to inadequate healthcare facilities and lack of access to healthcare. Without qualified health care professionals and fully equipped health facilities, programs to assist patients with medicines (both patented and unpatented) are of little use.

Additionally, chronic diseases are on the rise in India and infectious diseases continue to afflict Indian patients. India has the highest prevalence of tuberculosis (TB) in the world, 60 percent of the world’s heart disease, and malaria has staged a comeback after its near eradication in the 1960s. An estimated 40.9 million Indian patients suffer from diabetes, the highest number in the world, and 30 million people are infected with Hepatitis B Virus (HBV).

Global Health Progress recognizes this serious situation and calls on joint action among local leaders and diverse global stakeholders to implement sustainable, innovative solutions. Fortunately, Indian communities have successful and long-standing collaborations with biopharmaceutical companies and other international partners.

The full report, which features examples of India’s successful and long-standing collaborations with international partners, is available here:
http://globalhealthprogress.org/mediacenter/index.php/global-health-progress-report…

Via EPR Network
More Healthcare press releases